Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Chad Robins earned $1.72M in total compensation at Adaptive Biotechnologies, including $663.00K salary, $318.24K bonus and $716.86K in stock. Most recently sold 439,138 shares in Mar 2025. Currently holds stock worth $39.96M. Has donated $1.48M in stock to charitable causes. Has led Adaptive Biotechnologies for over 14 years.

Compensation History

Annual executive compensation data for Chad Robins, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$1.72M

Salary

$663.00K

Bonus

$318.24K

Other

$22.32K

Salary

$663.00K

Board Justification

The compensation philosophy emphasizes performance-based pay, aligning executive compensation with company performance and shareholder interests.

Bonus

$318.24K

Board Justification

Annual incentive based on the achievement of corporate goals, with a payout of 60% of the target due to mixed performance against set goals.

Other Compensation

$22.32K

Board Justification

Other compensation includes life insurance premiums, 401(k) match, and transportation services.

Restricted Stock

$716.86K78.95K RSU

Board Justification

Vested stock awards include RSUs that vested in 2023, with a total of 78,949 shares.

Performance Metrics

Performance metrics include revenue targets and operational efficiency goals, with a focus on achieving corporate objectives.

A

Chad Robins

Founder and CEO of Adaptive Biotechnologies

Education

MBA from Wharton School, University of Pennsylvania

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

June 15, 1976 - 49 years ago

CEO of Adaptive Biotechnologies for

14 years 11 months (Jan 2011 - Present)

Previous Experience

Co-Founder of Adaptive Biotechnologies

Holdings

Track Chad Robins's stock holdings and portfolio value over time.

Total Stock Sold

$50.91M

ADPT

$50.91M

2,236,130 ADPT shares

What if they kept their stock?

If Chad Robins didn't sell their stock, today they would have:
Extra ADPT2,236,130 shares worth $32.98M.
This is -35.22% and $17.93M less than what they got when they sold the stock.

Charitable Transactions

ADPT

100,000 shares

ADPT

Recent Charitable Transactions

ADPT

100,000 shares

ADPT

May 19, 2020

Charity

Insider Trading

Chad Robins's recent stock transactions, purchases, and sales filed with the SEC.

ADPT

$3.16M

ADPT at $7.20/share

Mar 4, 2025

Sale

ADPT

1,204,234 shares

ADPT

Mar 4, 2025

Received

ADPT

$2.41M

ADPT at $8.45/share

Feb 19, 2025

Sale

ADPT

$3.98M

ADPT at $8.47/share

Feb 13, 2025

Sale

ADPT

$167.19K

ADPT at $3.44/share

Mar 4, 2024

Sale

ADPT

354,610 shares

ADPT

Mar 4, 2024

Received

ADPT

354,610 shares

ADPT

Mar 6, 2023

Received

ADPT

$528.78K

ADPT at $11.90/share

Mar 7, 2022

Sale

ADPT

$53.13K

ADPT at $12.01/share

Mar 4, 2022

Sale

ADPT

247,117 shares

ADPT

Mar 4, 2022

Received

Rivals

Compare Chad Robins with competitor CEOs and industry peers.